Close
  • Home
  • About Us
  • Our Services
  • Blog
  • Contact
  • EnglishEnglish
    • FrançaisFrançais
    • 中文 (中国)中文 (中国)
  • Home
  • About Us
  • Our Services
  • Blog
  • Contact
  • EnglishEnglish
    • FrançaisFrançais
    • 中文 (中国)中文 (中国)
Linkedin Weixin

  • Home
  • About Us
  • Our Services
  • Blog
  • Contact
  • EnglishEnglish
    • FrançaisFrançais
    • 中文 (中国)中文 (中国)
Linkedin Weixin

Conference  ·  Medical device

Medical devices panorama in France

By lscconsultingfr 

The Medical Devices Panorama Day, organized by SNITEM, was held at the Cité des sciences et de l’industrie – Paris. It was divided into 4 parts: a numerical overview of the DM sector in France, a retrospective analysis of the Covid crisis and its impact on the market, a summary of the sector’s development issues and a prospective assessment.

Following the Covid crisis, the number of MD companies presenting on the market has decreased: 126 companies have left the market and 63 have entered it, leading to a negative balance and bringing the number of players down to 1,440, a drop of 4.5% (1,502 companies in 2019).

This disruption results in a change in the medical device landscape. The new entrants are 32% start-ups positioned on e-health MDs, 28% on equipment MDs, 22% on single-use MDs and 18% on IVD manufacturing.

The new regulation (applicable since May 2021) leads to a significant increase in the requirements expected from the manufacturer for CE marking. In order to accelerate access to innovative devices, two derogatory procedures have been put in place:

  • The innovation package: this consists of early and derogatory coverage of medical devices and innovative procedures, in condition of the completion of clinical and possibly medico-economic studies to provide the missing data.
  • The early access system: Resulting from the law on the financing of social security for 2020 and translated by the decree of February 23, 2021, the system of  responsibility assumption allows the marketing of a CE marked medical device, at the end of the studies, for a period of one year (renewable once)


Regarding the recruitment in the field of MD industry. There is a strong tension on human resources, mainly talents specialized in regulatory affairs, which are strongly solicited after the new regulation. This raises recruitment difficulties.


Innovative Startups Day by Snitem
Previous Article
2022 SANTEXPO Exhibition Day
Next Article

LSC CONSULTING

Home
About Us
Blog
Contact

OUR SERVICES

Market Access China
Market Access Europe
International Business Strategy
Distribution Management
Financing
Mergers & Acquisitions
PR Activities

INFORMATIONS

Legal Notice
Privacy Policy
Terms of Use

108, Avenue Denfert-Rochereau
75014 Paris FRANCE

contact@zouglobal.fr

© LSC CONSULTING
 

Loading Comments...